Ups And Downs Of Artificial Intelligence: IBM Stops Sales, Development Of Watson For Drug Discovery; Hospitals Learn From EHRs

While revenue and earnings have been lackluster for Watson for Drug Discovery, other companies are making profits in developing software that improves the clinical trials process for drugs. Also in the news: Hospitals are making improvements by using data from certain electronic health record systems.

from Kaiser Health News http://bit.ly/2ZlZVKL